Blue Trust Inc. Has $195,000 Stock Holdings in Avantor, Inc. (NYSE:AVTR)

Blue Trust Inc. increased its stake in shares of Avantor, Inc. (NYSE:AVTR) by 414.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,547 shares of the company’s stock after acquiring an additional 6,080 shares during the quarter. Blue Trust Inc.’s holdings in Avantor were worth $195,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of AVTR. Versant Capital Management Inc raised its position in shares of Avantor by 2,003.6% during the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock valued at $25,000 after buying an additional 1,102 shares during the last quarter. UMB Bank n.a. acquired a new position in Avantor in the 3rd quarter valued at approximately $49,000. GAMMA Investing LLC lifted its position in shares of Avantor by 89.9% in the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock worth $70,000 after acquiring an additional 1,285 shares during the period. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH acquired a new stake in shares of Avantor during the 1st quarter worth approximately $93,000. Finally, ORG Partners LLC increased its position in shares of Avantor by 5,773.0% during the second quarter. ORG Partners LLC now owns 5,873 shares of the company’s stock valued at $122,000 after purchasing an additional 5,773 shares during the period. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, CAO Steven W. Eck sold 3,525 shares of the company’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $25.06, for a total transaction of $88,336.50. Following the transaction, the chief accounting officer now owns 29,544 shares in the company, valued at $740,372.64. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 1.50% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages recently commented on AVTR. Barclays reduced their target price on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday. Robert W. Baird lifted their target price on shares of Avantor from $26.00 to $27.00 and gave the company an “outperform” rating in a research report on Monday, July 29th. Evercore ISI lowered their target price on shares of Avantor from $28.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 2nd. Citigroup cut shares of Avantor from a “buy” rating to a “neutral” rating and cut their price target for the stock from $30.00 to $23.00 in a research note on Wednesday, July 10th. Finally, TD Cowen lifted their price objective on Avantor from $28.00 to $31.00 and gave the company a “buy” rating in a report on Monday, July 29th. Three research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, Avantor presently has a consensus rating of “Moderate Buy” and an average price target of $27.79.

Avantor Stock Down 3.6 %

Shares of AVTR opened at $22.43 on Friday. The company has a market capitalization of $15.23 billion, a P/E ratio of 57.50, a PEG ratio of 2.93 and a beta of 1.33. Avantor, Inc. has a one year low of $16.63 and a one year high of $28.00. The business’s 50 day simple moving average is $25.55 and its 200-day simple moving average is $24.30. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.59 and a quick ratio of 1.05.

Avantor (NYSE:AVTR) last issued its quarterly earnings data on Friday, July 26th. The company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.02. The firm had revenue of $1.70 billion during the quarter, compared to the consensus estimate of $1.70 billion. Avantor had a return on equity of 12.40% and a net margin of 5.28%. As a group, sell-side analysts predict that Avantor, Inc. will post 1.01 EPS for the current fiscal year.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.